217 related articles for article (PubMed ID: 18509704)
1. Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments.
Ibrahim SM; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Mulcahy MF; Kulik L; Larson AC; Omary RA; Salem R
Cardiovasc Intervent Radiol; 2008; 31(6):1124-32. PubMed ID: 18509704
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
[TBL] [Abstract][Full Text] [Related]
3. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
4. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
[TBL] [Abstract][Full Text] [Related]
5. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
6. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
[TBL] [Abstract][Full Text] [Related]
7. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
[TBL] [Abstract][Full Text] [Related]
8. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
9. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
[TBL] [Abstract][Full Text] [Related]
10. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
[TBL] [Abstract][Full Text] [Related]
11. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
Sato KT; Lewandowski RJ; Mulcahy MF; Atassi B; Ryu RK; Gates VL; Nemcek AA; Barakat O; Benson A; Mandal R; Talamonti M; Wong CY; Miller FH; Newman SB; Shaw JM; Thurston KG; Omary RA; Salem R
Radiology; 2008 May; 247(2):507-15. PubMed ID: 18349311
[TBL] [Abstract][Full Text] [Related]
12. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
13. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
[TBL] [Abstract][Full Text] [Related]
14. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
[TBL] [Abstract][Full Text] [Related]
18. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
[TBL] [Abstract][Full Text] [Related]
19. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
20. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
Gaba RC; Riaz A; Lewandowski RJ; Ibrahim SM; Ryu RK; Sato KT; Omary RA; Salem R
J Vasc Interv Radiol; 2010 Aug; 21(8):1213-8. PubMed ID: 20598575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
